GlaxoSmithKline Plc said on Wednesday the U.S health regulator approved its lung disease drug Trelegy Ellipta for expanded use, making it the first inhaler delivering three drugs at once to be ...
Obstructive sleep apnoea (OSA) affects up to 1 billion people worldwide and is defined by repeated upper airway collapse ...
Cemiplimab significantly improved disease-free survival in high-risk CSCC, reducing recurrence or death risk by 68% compared ...
Microscopic dust mites can cause big problems for allergy sufferers, and you may not know they're in your home. Here are some ...
Medical experts speak out after Trump links Tylenol use during pregnancy to autism, a new poll looks at Republican frustrations, and more Length: Long Speed: 1.0x In an announcement on Sept. 22, ...
President Trump plans to announce Monday that using Tylenol while pregnant could potentially raise the risk of developing autism, sources told The Post. The Trump administration is expected to start ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. Daniel Payne reports on how the health industry and Washington influence ...
Officials will also tout the drug leucovorin as a potential autism treatment, in what President Donald Trump has billed as a “very important” announcement. The Trump administration is expected to ...
Results of the POSITIVE study assessing the treatment with tildrakizumab showed sustained improvements in skin clearance, psychological well-being, and improved partner quality of life in adults with ...
Banham Zoo keepers spent three years getting 16-year-old Mahiri to use her inhaler confidently Banham Zoo/Facebook Banham Zoo's 16-year-old giraffe, Mahiri, is believed to be the first giraffe in the ...
Recent evidence is leading to Chagas disease being classified as endemic in the U.S., which means it occurs regularly within an area, community or even country. Chagas disease is a potentially fatal ...
A massive Danish study reveals that despite the remarkable weight-loss benefits of semaglutide, more than half of adults without diabetes stop using it within a year. High costs, unpleasant side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback